معلومات عن هذه الحلقة
In this episode of Bladder Cancer Matters, host and survivor Rick Bangs sits down with ImmunityBio's Chief Medical Officer, Dr. Bobby Reddy, for a fascinating, hopeful look at the future of bladder cancer treatment.
They unpack how next-generation immunotherapies like ANKTIVA—paired with innovative approaches to BCG—are reshaping care for patients, especially those with limited options, while also tackling real-world challenges like ongoing BCG shortages.
Dr. Reddy breaks down the science in a way that's accessible, highlighting how activating the body's own immune system could lead to longer-lasting responses and even help patients avoid more invasive treatments. Tune in to this conversation about progress and possibility.
الإنجليزية
الولايات المتحدة
النص 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
البحث في الحلقات الماضية
البحث في الحلقات السابقة من Bladder Cancer Matters.
حلقات أخرى في هذا البودكاست
In this powerful episode of Bladder Cancer Matters, a podcast by the Bladder Cancer Advocacy Network, host and survivor Rick Bangs sits down with Vanderbilt nurse Bree Duncan to explore a groundbreaking new role dedicated solely to supporting women with bladder cancer.
Created through the vision …
In this episode of Bladder Cancer Matters, host Rick Bangs sits down with urologic oncologist Dr. Minhaj Siddiqui to break down a critical but often overlooked gap in bladder cancer care—and what it means for patients.
They explore how non-muscle-invasive bladder cancer is treated, why a simple st…
In this episode of Bladder Cancer Matters, host Rick Bangs speaks with Dr. Josefa Briceno of AstraZeneca about why bladder cancer care may be at a true turning point. From exploring immunotherapy earlier in the disease journey — even around the time of surgery — to strengthening collaboration betwe…
In this powerful episode of Bladder Cancer Matters, Rick Bangs sits down with Mike Vasallo, a high school assistant principal diagnosed with early-onset bladder cancer at 46 who turned fear and uncertainty into purpose.
Mike shares his raw, honest journey through diagnosis, treatment and recovery—…
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من Bladder Cancer Advocacy Network، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.
تعديل
شكراً على مساعدتنا في الحفاظ على قاعدة بيانات البودكاست مُحدَّثة.
